Autoimmune rheumatic disease associated symptoms in fibromyalgia patients and their influence on anxiety, depression and somatisation: a comparative study

Basit Öğe Kaydı
dc.contributor.authorDonmez, S.
dc.contributor.authorPamuk, O. N.
dc.contributor.authorUmit, E. G.
dc.contributor.authorTop, M. S.
dc.date.accessioned2024-06-12T11:01:56Z
dc.date.available2024-06-12T11:01:56Z
dc.date.issued2012
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective. In this study we evaluated the frequency of autoimmune rheunzatic disease associated major symptoms in fibromyalgia (FM) patients, and the association between their presence and anxiety, depression and somatisation. Methods. Two hundred and thirty-two FM, 78 systemic lupus erythematosus (SLE) patients and 70 healthy controls were included. All subjects were questioned face-to-face for the presence of autoimmune rheumatic disease-associated symptoms and antinuclear antibody (ANA) was determined. All FM patients were questioned for the severity of pain and symptoms of FM by using a visual analogue scale. In addition, all subjects were interrogated for anxiety, depression, somatic symptoms and neuropathic pain by using different validated questionnaires. Results. FM patients had significantly higher frequency of photosensitivity (27.6% vs. 11.4%) and Raynaud phenomenon (22% vs. 10%) when compared to controls (p-values, 0.005 and 0.026). FM patients had significantly lower frequencies of photosensitivity, oral ulcers, xerostomia, and xerophthalmia than SLE patients (all p-values <0.001). ANA positivity was 11.8% in FM patients and 7.1% in healthy controls. ANA-positive and negative FM patients had similar frequencies of autoimmune rheumatic disease symptoms. FM patients with photosensitivity had higher anxiety (p=0.002), somatic symptoms (p=0.015) and neuropathic pain (p=0.03) scores than others. FM patients with Raynaud had higher anxiety (p=0.004), depression (p=0.001), somatic symptom (p<0.001) and neuropathic pain scores than others. Conclusion. The presence of which findings in FM seems to be associated with anxiety, depression, and somatisation rather than ANA positivity and disease severity.en_US
dc.identifier.endpageS69en_US
dc.identifier.issn0392-856X
dc.identifier.issue6en_US
dc.identifier.pmid23137613en_US
dc.identifier.scopus2-s2.0-84874970477en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpageS65en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21084
dc.identifier.volume30en_US
dc.identifier.wosWOS:000313602400010en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherClinical & Exper Rheumatologyen_US
dc.relation.ispartofClinical And Experimental Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFibromyalgiaen_US
dc.subjectSystemic Lupus Erythematosusen_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectSomatisationen_US
dc.subjectSystemic-Lupus-Erythematosusen_US
dc.subjectAntinuclear Antibodiesen_US
dc.subjectImpact Questionnaireen_US
dc.subjectNeuropathic Symptomsen_US
dc.subjectLeeds Assessmenten_US
dc.subjectPain Scaleen_US
dc.subjectClassificationen_US
dc.subjectMulticenteren_US
dc.subjectPrevalenceen_US
dc.subjectValidationen_US
dc.titleAutoimmune rheumatic disease associated symptoms in fibromyalgia patients and their influence on anxiety, depression and somatisation: a comparative studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu